131 related articles for article (PubMed ID: 6197151)
21. Purification of autoantibodies to myelin basic protein by antigen specific affinity chromatography from cerebrospinal fluid IgG of multiple sclerosis patients. Immunoreactivity studies with human myelin basic protein.
Warren KG; Catz I
J Neurol Sci; 1991 May; 103(1):90-6. PubMed ID: 1713953
[TBL] [Abstract][Full Text] [Related]
22. CSF myelin basic protein levels in leptomeningeal metastases. Relationship to disease activity.
Siegal T; Ovadia H; Yatsiv I; Abramsky O
J Neurol Sci; 1987 Apr; 78(2):165-73. PubMed ID: 2437254
[TBL] [Abstract][Full Text] [Related]
23. Cerebrospinal myelin basic protein in multiple sclerosis. Identification of two groups of patients with acute exacerbation.
Martin-Mondière C; Jacque C; Delassalle A; Césaro P; Carydakis C; Degos JD
Arch Neurol; 1987 Mar; 44(3):276-8. PubMed ID: 2435271
[TBL] [Abstract][Full Text] [Related]
24. Myelin basic protein in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.
Biber A; Englert D; Dommasch D; Hempel K
J Neurol; 1981; 225(4):231-6. PubMed ID: 6169802
[TBL] [Abstract][Full Text] [Related]
25. Cerebrospinal fluid autoantibodies to myelin basic protein in multiple sclerosis patients. Detection during first exacerbations and kinetics of acute relapses and subsequent convalescent phases.
Warren KG; Catz I
J Neurol Sci; 1989 Jun; 91(1-2):143-51. PubMed ID: 2473170
[TBL] [Abstract][Full Text] [Related]
26. Intrathecal synthesis of autoantibodies to myelin basic protein in multiple sclerosis.
Catz I; Warren KG
Can J Neurol Sci; 1986 Feb; 13(1):21-4. PubMed ID: 2420428
[TBL] [Abstract][Full Text] [Related]
27. Autoantibodies to myelin basic protein are not present in the serum and CSF of MS patients.
Brokstad KA; Page M; Nyland H; Haaheim LR
Acta Neurol Scand; 1994 Jun; 89(6):407-11. PubMed ID: 7526591
[TBL] [Abstract][Full Text] [Related]
28. Measurement of myelin basic protein by radioimmunoassay in closed head trauma, multiple sclerosis and other neurological diseases.
Mukherjee A; Vogt RF; Linthicum DS
Clin Biochem; 1985 Oct; 18(5):304-7. PubMed ID: 2414035
[TBL] [Abstract][Full Text] [Related]
29. Soluble ICAM-1, demyelination, and inflammation in multiple sclerosis and acute optic neuritis.
Petersen AA; Sellebjerg F; Frederiksen J; Olesen J; Vejlsgaard GL
J Neuroimmunol; 1998 Aug; 88(1-2):120-7. PubMed ID: 9688333
[TBL] [Abstract][Full Text] [Related]
30. CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone.
Frequin ST; Barkhof F; Lamers KJ; Hommes OR; Borm GF
Acta Neurol Scand; 1992 Sep; 86(3):291-7. PubMed ID: 1384263
[TBL] [Abstract][Full Text] [Related]
31. The relationship between levels of cerebrospinal fluid myelin basic protein and IgG measurements in patients with multiple sclerosis.
Warren KG; Catz I
Ann Neurol; 1985 May; 17(5):475-80. PubMed ID: 2408558
[TBL] [Abstract][Full Text] [Related]
32. Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritis.
Modvig S; Degn M; Horwitz H; Cramer SP; Larsson HB; Wanscher B; Sellebjerg F; Frederiksen JL
PLoS One; 2013; 8(10):e77163. PubMed ID: 24116216
[TBL] [Abstract][Full Text] [Related]
33. Cerebrospinal fluid levels of myelin basic protein-like material and soluble interleukin-2 receptor in multiple sclerosis.
Fesenmeier JT; Whitaker JN; Herman PK; Walker DP
J Neuroimmunol; 1991 Oct; 34(1):77-80. PubMed ID: 1716642
[TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial.
Rolak LA; Beck RW; Paty DW; Tourtellotte WW; Whitaker JN; Rudick RA
Neurology; 1996 Feb; 46(2):368-72. PubMed ID: 8614496
[TBL] [Abstract][Full Text] [Related]
35. Research approaches on the diagnosis of multiple sclerosis by CSF examination.
Schmidt RM; Kuppe G; Kissig B; Ludewig R; Neumann V
Schweiz Arch Neurol Psychiatr (1985); 1987; 138(3):13-22. PubMed ID: 2441464
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid antibodies to myelin basic protein in acute idiopathic optic neuritis.
Warren KG; Catz I; Bauer C
Ann Neurol; 1988 Mar; 23(3):297-9. PubMed ID: 2454070
[TBL] [Abstract][Full Text] [Related]
37. Optic neuritis is associated with myelin basic protein and proteolipid protein reactive cells producing interferon-gamma, interleukin-4 and transforming growth factor-beta.
Link J; Söderström M; Kostulas V; Olsson T; Höjeberg B; Ljungdahl A; Link H
J Neuroimmunol; 1994 Jan; 49(1-2):9-18. PubMed ID: 7507500
[TBL] [Abstract][Full Text] [Related]
38. The effect of intrathecal MBP synthetic peptides containing epitope P85 VVHFFKNIVTP96 on free anti-MBP levels in acute relapsing multiple sclerosis.
Warren KG; Catz I
J Neurol Sci; 1997 May; 148(1):67-78. PubMed ID: 9125392
[TBL] [Abstract][Full Text] [Related]
39. Neutralization of anti-myelin basic protein by cerebrospinal fluid of multiple sclerosis patients in clinical remission.
Warren KG; Catz I
J Neurol Sci; 1988 Dec; 88(1-3):185-94. PubMed ID: 2465390
[TBL] [Abstract][Full Text] [Related]
40. Myelin basic protein in the cerebrospinal fluid of patients infected with HIV.
Pfister HW; Einhäupl KM; Wick M; Fateh-Moghadam A; Huber M; Schielke E; Goebel FD; Matuschke A; Heinrich B; Bogner JR
J Neurol; 1989 Jul; 236(5):288-91. PubMed ID: 2474637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
